News

Filter

Current filters:

None

64 to 73 of 97199 results

ETH and University of Zurich launch new translational center

ETH and University of Zurich launch new translational center

15-12-2014

Switzerland’s ETH Zurich and the University of Zurich (UZH) are taking their long-standing partnership…

ETH ZurichFinancialPharmaceuticalResearchSwitzerland

Australian mid-year economic and fiscal outlook does not show cost increases for PBS

Australian mid-year economic and fiscal outlook does not show cost increases for PBS

15-12-2014

The Mid-Year Economic and Fiscal Outlook released by the Australian government did not indicate any cost…

AustraliaHealthcare in AustraliaMedicines AustraliaPharmaceuticalRegulation

FDA approves third indication for Lilly’s Cyramza

FDA approves third indication for Lilly’s Cyramza

13-12-2014

The US Food and Drug Administration on Friday expanded the approved use of pharma major Eli Lilly’s…

CyramzaEli LillyOncologyPharmaceuticalRegulationUSA

Bayer fails in Indian Nexavar patent appeal

Bayer fails in Indian Nexavar patent appeal

13-12-2014

German pharma major Bayer suffered a significant disappointment on Friday, when India’s Supreme Court…

BayerIndiaLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

Plans unveiled for Singapore’s biologics manufacturing industry

Plans unveiled for Singapore’s biologics manufacturing industry

13-12-2014

The Singapore Workforce Development Agency (WDA), Singapore Economic Development Board (EDB) and Biopharmaceutical…

AbbVieAmgenBaxterBiotechnologyGlaxoSmithKlineLonzaNovartisProductionRocheSingapore

Dompé announces promising preliminary data on reparixin in triple negative breast cancer

Dompé announces promising preliminary data on reparixin in triple negative breast cancer

12-12-2014

Italian biopharma company Dompé has conducted the first study looking at the combination of its reparixin…

DompeItalyOncologyPharmaceuticalreparixinResearch

Tamoxifen offers long period of protection against breast cancer but does not reduce mortality

Tamoxifen offers long period of protection against breast cancer but does not reduce mortality

12-12-2014

A study published in The Lancet Oncology and presented at the San Antonio Breast Cancer Symposium showed…

Breast cancerOncologyPharmaceuticalResearchtamoxifen

64 to 73 of 97199 results

Back to top